Global Ventricular Assist Devices Market Size & Trends Report Segmented by Product (LVAD, RVAD, BiVAD, TAH), Flow Type (Continuous & Pulsatile), Application (Bridge to Transplant, Destination Therapy) Industry Analysis & Regional Forecast to 2030
The global ventricular assist devices (VAD) market is projected to grow at a CAGR of ~11% during the forecast period. This growth is primarily driven by the rising prevalence of heart failure, the growing geriatric population, innovations such as magnetically levitated pumps and percutaneous systems, increasing adoption of VADs as destination therapy, favourable reimbursement policies, and the shift toward minimally invasive and wearable VADs. However, the high cost of VAD implantation and maintenance continues to be a major restraint for broader adoption. To learn more about the research report, download a sample report.
Overview
Ventricular assist devices (VADs) are mechanical pumps that support heart function and blood flow in individuals with weakened hearts, particularly those experiencing advanced heart failure. These devices are surgically implanted to assist either the left ventricle (LVAD), right ventricle (RVAD), or both (BiVAD) in pumping blood effectively to the rest of the body. VADs are mainly used as a bridge to transplant, providing life-sustaining support for patients waiting for a heart transplant, or as destination therapy for patients who are ineligible for transplant. They are also employed as a bridge to recovery, allowing the heart to rest and regain function in case of temporary heart failure. VADs can be implantable for long-term use or extracorporeal (outside the body) for short-term or emergency support, such as in cases of cardiogenic shock. These devices are commonly used in hospitals with advanced cardiac care units and are increasingly adopted in specialty clinics. Continuous-flow VADs are currently the most widely adopted devices as they are smaller and more durable. With the rise in cases of heart failure globally, VADs play a crucial role in improving survival, reducing symptoms, and enhancing the quality of life for patients with end-stage cardiac conditions.
To learn more about this report, download the PDF brochure
Increasing prevalence of heart failure is fueling growth of the ventricular assist devices market
One of the primary drivers of the ventricular assist devices (VAD) market is the increasing global prevalence of heart failure. According to an article published by NIH in 2023, over 64 million people worldwide had heart failure, and this number is steadily rising, primarily due to aging populations, especially in developed regions. The surge is also due to growing adoption of sedentary lifestyles, poor dietary habits, and higher rates of hypertension, diabetes, and obesity.
As heart failure advances to more severe stages, patients often face debilitating symptoms like breathlessness, fatigue, and fluid retention, which greatly impact their quality of life and survival. In advanced cases, traditional treatments like medication or lifestyle changes become less effective, and heart transplants are considered the gold standard. However, due to the long wait times for transplants, ventricular assist devices have become an essential alternative. VADs can serve as a bridge-to-transplant, bridge-to-recovery, or even as destination therapy for patient’s ineligible for transplant, providing vital circulatory support and enhancing both survival and quality of life. The increasing burden of heart failure thus directly fuels the demand for VADs across hospitals and cardiac care centers worldwide.
To learn more about this report, download the PDF brochure
Increasing market adoption of minimally invasive and percutaneous VADs
The VADs market is experiencing a major shift with the increasing use of minimally invasive, percutaneous devices (pVADs) for acute circulatory support. Unlike traditional surgically implanted VADs, pVADs are inserted through small catheters, usually via the femoral artery, avoiding open-heart surgery. This change is mainly driven by the urgent need to lower procedural risk, decrease vascular complications, and shorten patient recovery times, especially in emergencies like cardiogenic shock and high-risk percutaneous coronary interventions (PCI).
With the surge in the number of heart failures, particularly among older populations and those with multiple health issues, clinicians are increasingly relying on pVADs for quick and effective hemodynamic support. These devices provide the benefit of delivering high blood flow up to 5 litres per minute, through small catheters as narrow as 10–14 French and are simpler to implant and remove, which is vital in time-critical cardiac procedures. Recent clinical trial outcomes, including devices from companies like Magenta Medical, Supira Medical, and CSI, have shown that percutaneous options can be both safe and highly effective. Consequently, pVADs are rapidly becoming the first choice for short-term mechanical circulatory support, particularly in interventional cardiology settings.
Recent developments in the ventricular assist devices market
Recent FDA approvals highlight growing innovation and clinical refinement in the VAD market. These developments are streamlining access to safer and more advanced device options. For instance,
- In August 2024, Abbott announced that the FDA had approved a change to its label that will support, exclusively, patients who receive a HeartMate 3 left ventricular assist device to experience superior clinical outcomes by eliminating aspirin as part of routine patient management
- In August 2023, the FDA designated magAssist’s NyokAssist interventional VAD as a “Breakthrough Device”, the first cardiac device from China to earn this title. This title will accelerate its regulatory review and highlights its potential to expand VAD access, especially amid rising global heart failure cases
Competitive Landscape Analysis
The global ventricular assist devices market is marked by the presence of established and emerging market players such as Abbott Laboratories; Medtronic Plc; Berlin Heart GmbH; Jarvik Heart, Inc.; Cardiac Assist, Inc (LivaNova PLC); Evaheart, Inc.; Abiomed, Inc. (Johnson & Johnson company); SynCardia Systems, LLC; Sun Medical Technology Research Corporation; BiVACOR Inc; and AdjuCor GmbH among others. Some of the key strategies adopted by market players include new product development, strategic partnerships and collaborations, and geographic expansion.
Report Scope
| Report Metric | Details |
| Base Year Considered | 2024 |
| Historical Data | 2023 - 2024 |
| Forecast Period | 2025 – 2030 |
| Growth Rate | ~11% |
| Market Drivers |
|
| Attractive Opportunities |
|
| Segment Scope | Product, Flow Type, Application, and End-user |
| Regional Scope |
|
| Key Companies Mapped | Abbott Laboratories; Medtronic Plc; Berlin Heart GmbH; Jarvik Heart, Inc.; Cardiac Assist, Inc (LivaNova PLC); Evaheart, Inc.; Abiomed, Inc. (Johnson & Johnson company); SynCardia Systems, LLC; Sun Medical Technology Research Corporation; BiVACOR Inc; and AdjuCor GmbH among others |
| Report Highlights | Market Size & Forecast, Growth Drivers & Restraints, Trends, Competitive Analysis |
Global Ventricular Assist Devices Market Segmentation
This report by Medi-Tech Insights provides the size of the global ventricular assist devices market at the regional- and country-level from 2023 to 2030. The report further segments the market based on product, flow type, application and end-user.
Market Size & Forecast (2023-2030), By Product, USD Million
- Left Ventricular Assist Device (LVAD)
- Right Ventricular Assist Device (RVAD)
- Bi-Ventricular Assist Device (BiVAD)
- Total Artificial Heart
Market Size & Forecast (2023-2030), By Pump Flow Type, USD Million
- Continuous Flow
- Pulsatile Flow
Market Size & Forecast (2023-2030), By Application, USD Million
- Bridge to Transplant (BTT)
- Destination Therapy (DT)
- Bridge to Recovery (BTR)
- Others
Market Size & Forecast (2023-2030), By End-user, USD Million
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
- Others
Market Size & Forecast (2023-2030), By Region, USD Million
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Rest of Asia Pacific
- Latin America
- Middle East & Africa
Key Strategic Questions Addressed
- What is the market size & forecast of the ventricular assist devices market?
- What are historical, present, and forecasted market shares and growth rates of various segments and sub-segments of the ventricular assist devices market?
- What are the key trends defining the market?
- What are the major factors impacting the market?
- What are the opportunities prevailing in the market?
- Which region has the highest share in the global market? Which region is expected to witness the highest growth rate in the next 5 years?
- Who are the major players operating in the market?
- What are the key strategies adopted by players?
- Introduction
- Introduction
- Market Scope
- Market Definition
- Segments Covered
- Regional Segmentation
- Research Timeframe
- Currency Considered
- Study Limitations
- Stakeholders
- List of Abbreviations
- Key Conferences and Events (2025-2026)
- Research Methodology
- Secondary Research
- Primary Research
- Market Estimation
- Bottom-Up Approach
- Top-Down Approach
- Market Forecasting
- Executive Summary
- Ventricular Assist Devices Market Snapshot (2025-2030)
- Segment Overview
- Regional Snapshot
- Competitive Insights
- Market Overview
- Market Dynamics
- Drivers
- Increasing prevalence of heart failure
- Shortage of donor hearts for transplantation
- Rising adoption of VADs as destination therapy
- Growing demand for minimally invasive and wearable VADs
- Increased awareness among patients and providers
- Restraints
- High costs of VADs and implantation procedures
- Limited availability of skilled cardiac surgeons
- Risk of device-related infections and complications
- Opportunities
- Developments in magnetically levitated and continuous-flow technologies
- Increasing R&D and growing focus on pediatric VAD
- Rising demand for percutaneous VADs
- Expansion into emerging markets
- Key Market Trends
- Shift toward fully implantable VAD systems
- Clinical trials expanding indications for VADs
- Integration of remote monitoring and smart data analytics
- Unmet Market Needs
- Industry Speaks
- Drivers
- Market Dynamics
- Global Ventricular Assist Devices Market Size & Forecast (2023-2030), By Product, USD Million
- Introduction
- Left Ventricular Assist Device (LVAD)
- Right Ventricular Assist Devices (RVAD)
- Bi-Ventricular Assist Device (BiVAD)
- Total Artificial Heart
- Global Ventricular Assist Devices Market Size & Forecast (2023-2030), By Flow Type, USD Million
- Introduction
- Continuous Flow
- Pulsatile Flow
- Global Ventricular Assist Devices Market Size & Forecast (2023-2030), By Application Type, USD Million
- Introduction
- Bridge to Transplant (BTT)
- Destination Therapy (DT)
- Bridge to Recovery (BTR)
- Others
- Global Ventricular Assist Devices Market Size & Forecast (2023-2030), By End-user, USD Million
- Introduction
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
- Others
- Global Ventricular Assist Devices Market Size & Forecast (2023-2030), By Region, USD Million
- Introduction
- North America Ventricular Assist Devices Market Size & Forecast (2023-2030), By Country, USD Million
- US
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Flow Type (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Canada
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Flow Type (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- US
- Europe Ventricular Assist Devices Market Size & Forecast (2023-2030), By Country, USD Million
- UK
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Flow Type (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Germany
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Flow Type (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- France
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Flow Type (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Italy
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Flow Type (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Spain
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Flow Type (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Rest of Europe
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Flow Type (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- UK
- Asia Pacific (APAC) Ventricular Assist Devices Market Size & Forecast (2023-2030), By Country, USD Million
- China
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Flow Type (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Japan
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Flow Type (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- India
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Flow Type (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Rest of Asia Pacific
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Flow Type (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- China
- Latin America (LATAM) Ventricular Assist Devices Market Size & Forecast (2023-2030), USD Million
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Flow Type (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Middle East & Africa (MEA) Ventricular Assist Devices Market Size & Forecast (2023-2030), USD Million
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Flow Type (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Competitive Landscape
- Key Players and their Competitive Positioning
- Key Player Comparison
- Segment-wise Player Mapping
- Market Share Analysis (2024)
- Company Categorization Matrix
- Dominants/Leaders
- New Entrants
- Emerging Players
- Innovative Players
- Key Strategies Assessment, By Player (2022-2025)
- New Product Launches
- Partnerships, Agreements, & Collaborations
- Mergers & Acquisitions
- Geographic Expansion
- Key Players and their Competitive Positioning
- Company Profiles*
(Business Overview, Financial Performance**, Products Offered, Recent Developments)
- Abbott Laboratories
- Medtronic Plc
- Berlin Heart GmbH
- Jarvik Heart Inc
- Cardiac Assist Inc (LivaNova PLC)
- Evaheart Inc
- Abiomed Inc (Johnson & Johnson company)
- SynCardia Systems, LLC
- Sun Medical Technology Research Corporation
- BiVACOR Inc
- AdjuCor GmbH
- Other Prominent Players
Note: *Indicative list
**For listed companies
The study has been compiled based on extensive primary and secondary research.
Secondary Research (Indicative List)
Primary Research
To validate research findings (market size & forecasts, market segmentation, market dynamics, competitive landscape, key industry trends, etc.), extensive primary interviews were conducted with both supply and demand-side stakeholders.
Supply Side Stakeholders:
- Senior Management Level: CEOs, Presidents, Vice-Presidents, Directors, Chief Technology Officers, Chief Commercial Officers
- Mid-Management Level: Product Managers, Sales Managers, Brand Managers, R&D Managers, Business Development Managers, Consultants
Demand Side Stakeholders:
- Stakeholders from Hospitals, Ambulatory Surgical Centers, Specialty Clinics, and Others
Breakdown of Primary Interviews
Market Size Estimation
Both ‘Top-Down & Bottom-Up Approaches’ were used to derive market size estimates and forecasts
Data Triangulation
Research findings derived through secondary sources & internal analysis was validated with Primary Interviews, Internal Knowledge Repository and Company’s Sales Data
Features of the Report
- Comprehensive Market Coverage
- Market Size and Forecast
- Geographic & Segment Deep Dives
- Strategic Insights & Competitive Landscape
- Timely & Updated Data
- Growth Indicators & Future Outlook
- Quick Turnaround on Queries
- Analyst Support
- Report Customization Available
- Reports in PDF & Excel
